somo•v ABUS

The somo•v® Automated Breast Ultrasound (ABUS™) system, is the first and only ultrasound system developed and FDA approved* specifically for breast cancer screening in women with dense breast tissue.
 
 
somo•v® Automated Breast Ultrasound (ABUS™) INSIGHT system

This should be automatic –
for patients with dense breast tissue

U-Systems developed the somo•v ABUS technology as the foundation for a ground-breaking, prospective clinical study to evaluate the sensitivity of the somo•v ABUS system when used in combination with digital routine screening mammography in more than 15,500 women with dense breasts.

The result of 10 years of research and development, the somo•v ABUS system is designed to automatically scan a woman's breast capturing multiple ultrasound images and displaying them in 3D for review by a physician. somo•v ABUS is ideal for patients with dense breast tissue, where the effectiveness of mammography may be limited.

Learn more about this ground-breaking study at SOMOINSIGHTStudy.org

somo•v Performance Delivers Precise Anatomical Detail

The somo•v LHD14-6 high frequency 14 MHz automated ultra broadband transducer delivers a 3D volume view of 15cm x 17cm x 5.0cm. The high center-frequency significantly sharpens detail resolution while the ultra broadband performance simultaneously delivers distinct contrast differentiation, resulting in precise anatomical detail of complex breast tissues and structures.reviewsmall

somo•VIEWer Advanced 3D Workstation

Images generated from the somo•v ABUS system are sent to the somo•VIEWer Advanced 3D Workstation for interpretation, enabling fast, quick review and may be archived to a PACS or external storage of patient exams to optimize breast ultrasound screening workflow.

3D volumes are displayed in a patented, 2 mm thick coronal view slice from the skin to the chest wall using proprietary pattern recognition software. The result is a reading environment which allows for rapid and intuitive analysis of intricate breast anatomy and pathology.

Physicians can accurately review 3D image sets on the workstation in three minutes or less.**

ABUS_Cancer

* FDA PMA P110006

** ARRS 2012 Breast Imaging: Screening/Emerging Technologies Oral Abstract; Radiologist Interpretation Time for 3D Automated Breast Ultrasound Screening, R. Brem